Truist Financial’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
Truist Financial's RDY Position: Q1 2021 in Review
Truist Financial sold out of Dr. Reddy's Laboratories (RDY) in Q1 2021, closing a stake of 19,445 shares — an estimated $277K sold.
Truist Financial first reported a position in RDY in Q2 2020 and held it in 3 quarters. The position peaked at $277K in Q4 2020. 160 funds tracked by Wall St. Rank hold RDY as of Q1 2021.
- Truist Financial reported no remaining Dr. Reddy's Laboratories position as of Q1 2021 after selling out during the quarter.
- Truist Financial sold 19,445 Dr. Reddy's Laboratories shares in Q1 2021, an estimated $277K.
- Truist Financial first reported a position in Dr. Reddy's Laboratories in Q2 2020 and held it in 3 quarters.
- Truist Financial's Dr. Reddy's Laboratories position peaked at $277K in Q4 2020.
- 160 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2021.
Based on Truist Financial's 13F filing for Q1 2021, filed 17 May 2021.